Management of combined oral antithrombotic therapy by an antithrombotic stewardship program: A prospective study.

Zhang, Zhu Xian; Schroeder-Tanka, Jutta; Stooker, Wim; Wissen, Sanne; Khorsand, Nakisa

Zhang, Zhu Xian; Schroeder-Tanka, Jutta; Stooker, Wim; Wissen, Sanne; Khorsand, Nakisa.

Afiliação

Zhang ZX; Pharmacy Department, OLVG, Amsterdam, the Netherlands.
Schroeder-Tanka J; Department of Cardiology, OLVG, Amsterdam, The Netherlands.
Stooker W; Department of Cardiothoracic Surgery, Department of Intensive Care, OLVG, Amsterdam, The Netherlands.
Wissen S; Department of Internal Medicine, OLVG, Amsterdam, The Netherlands.
Khorsand N; Pharmacy Department, OLVG, Amsterdam, the Netherlands.

Br J Clin Pharmacol ; 88(9): 4092-4099, 2022 09.

Article em En | MEDLINE | ID: mdl-35384015

Assuntos

Fibrinolíticos; Inibidores da Agregação Plaquetária; Anticoagulantes; Humanos; Prescrição Inadequada/prevenção & controle; Inibidores da Agregação Plaquetária/uso terapêutico; Estudos Prospectivos

Palavras-chave

anticoagulation; antithrombotic; antithrombotic stewardship program; guideline adherence; platelet aggregation inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Fibrinolíticos Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google